Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarjei S Hveem

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Ebiomedicine|September 3, 2021
Automated assessment of CD8<sup>+</sup> T-lymphocytes and stroma fractions complement conventional staging of colorectal cancerDan Jiang, Tarjei S Hveem, Mark Glaire, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 16, 2026
Prognostic role of estrogen receptor, L1 cell adhesion molecule, and tumor grade in patients with endometrial carcinoma of no specific molecular profileWanja Kildal, Manohar Pradhan, Gunnar B Kristensen, et al.
Oncotarget|March 14, 2022
Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneityLudmila Gorunova, Kjetil Boye, Ioannis Panagopoulos, et al.
Cancers|July 27, 2022
Endometrial Carcinoma: Molecular Cytogenetics and Transcriptomic ProfileMarta Brunetti, Ioannis Panagopoulos, Valeria Vitelli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 6, 2019
Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancerElin Ersvær, Wanja Kildal, Ljiljana Vlatkovic, et al.
International Journal of Cancer|December 18, 2019
Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancerElin Ersvaer, Tarjei S Hveem, Ljiljana Vlatkovic, et al.
Experimental Hematology & Oncology|June 5, 2019
Novel <i>GTF2I</i>-<i>PDGFRB</i> and <i>IKZF1</i>-<i>TYW1</i> fusions in pediatric leukemia with normal karyotypeIoannis Panagopoulos, Marta Brunetti, Margrethe Stoltenberg, et al.
British Journal of Cancer|April 29, 2016
Chromatin changes predict recurrence after radical prostatectomyTarjei S Hveem, Andreas Kleppe, Ljiljana Vlatkovic, et al.
Histopathology|November 29, 2014
Computerized image analysis of the Ki-67 proliferation index in mantle cell lymphomaYngvild N Blaker, Marianne Brodtkorb, John Maddison, et al.
British Journal of Cancer|June 16, 2017
Tumour heterogeneity poses a significant challenge to cancer biomarker researchKarolina Cyll, Elin Ersvær, Ljiljana Vlatkovic, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Ebiomedicine|September 3, 2021
Automated assessment of CD8<sup>+</sup> T-lymphocytes and stroma fractions complement conventional staging of colorectal cancerDan Jiang, Tarjei S Hveem, Mark Glaire, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 16, 2026
Prognostic role of estrogen receptor, L1 cell adhesion molecule, and tumor grade in patients with endometrial carcinoma of no specific molecular profileWanja Kildal, Manohar Pradhan, Gunnar B Kristensen, et al.
Oncotarget|March 14, 2022
Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneityLudmila Gorunova, Kjetil Boye, Ioannis Panagopoulos, et al.
Cancers|July 27, 2022
Endometrial Carcinoma: Molecular Cytogenetics and Transcriptomic ProfileMarta Brunetti, Ioannis Panagopoulos, Valeria Vitelli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 6, 2019
Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancerElin Ersvær, Wanja Kildal, Ljiljana Vlatkovic, et al.
International Journal of Cancer|December 18, 2019
Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancerElin Ersvaer, Tarjei S Hveem, Ljiljana Vlatkovic, et al.
Experimental Hematology & Oncology|June 5, 2019
Novel <i>GTF2I</i>-<i>PDGFRB</i> and <i>IKZF1</i>-<i>TYW1</i> fusions in pediatric leukemia with normal karyotypeIoannis Panagopoulos, Marta Brunetti, Margrethe Stoltenberg, et al.
British Journal of Cancer|April 29, 2016
Chromatin changes predict recurrence after radical prostatectomyTarjei S Hveem, Andreas Kleppe, Ljiljana Vlatkovic, et al.
Histopathology|November 29, 2014
Computerized image analysis of the Ki-67 proliferation index in mantle cell lymphomaYngvild N Blaker, Marianne Brodtkorb, John Maddison, et al.
British Journal of Cancer|June 16, 2017
Tumour heterogeneity poses a significant challenge to cancer biomarker researchKarolina Cyll, Elin Ersvær, Ljiljana Vlatkovic, et al.
Pageof 2